Platelet a-Granule Fibrinogen, Albumin, and Immunoglobulin G Are Not Synthesized by Rat and Mouse Megakaryocytes by Handagama, Prem et al.
Wayne State University
DigitalCommons@WayneState
Department of Obstetrics and Gynecology
Research Publications
C.S. Mott Center for Human Growth and
Development
10-1-1990
Platelet a-Granule Fibrinogen, Albumin, and
Immunoglobulin G Are Not Synthesized by Rat
and Mouse Megakaryocytes
Prem Handagama
University of California
Daniel A. Rappolee
University of California, drappole@med.wayne.edu
Zena Werb
University of California
Jack Levin
University of California
Dorothy F. Bainton
University of California
This Article is brought to you for free and open access by the C.S. Mott Center for Human Growth and Development at
DigitalCommons@WayneState. It has been accepted for inclusion in Department of Obstetrics and Gynecology Research Publications by an
authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Handagama P, Rappolee DA, Werb Z, Levin J, Bainton DF. Platelet alpha-granule fibrinogen, albumin, and immunoglobulin G are not
synthesized by rat and mouse megakaryocytes. J. Clin Invest. 1990 Oct;86(4): 1364-1368. doi:10.1172/JCI114848
Available at: http://digitalcommons.wayne.edu/med_obgyn/1
Rapid Publication
Platelet a-Granule Fibrinogen, Albumin, and Immunoglobulin G
Are Not Synthesized by Rat and Mouse Megakaryocytes
Prom Handagama,* Daniel A. Rappolee,t Zena Werb,t Jack Levin,611 and Dorothy F. Bainton*
*Department ofPathology, *Laboratory ofRadiobiology and Environmental Health, and IDepartment ofLaboratory Medicine,
University ofCalifornia, San Francisco, California 94143; and Veterans Administration Medical Center (113A),
San Francisco, California 94121
Abstract
It has been assumed that endogenous synthesis by the platelet
precursor cell, the bone marrow megakaryocyte, is the major
source of platelet a-granule protein. To test this hypothesis, we
used mRNA phenotyping to detect in megakaryocytes the
presence of mRNA transcripts specific for various proteins.
Our results indicate that megakaryocytes synthesize platelet
factor 4, a protein relatively specific for platelets, but do not
express mRNA transcripts for the fibrinogen, albumin, or IgG
found in a-granules. We have previously shown that mega-
karyocytes endocytose circulating proteins, including fibrino-
gen, albumin, and IgG, and incorporate them into a-granules.
Thus, platelets appear to contain a unique type of secretory
granule whose contents originate by both endogenous synthesis
and endocytosis from plasma. Under basal conditions, the
source of a-granule fibrinogen is plasma. (J. Clin. Invest.
1990. 86:1364-1368). Key words: plasma proteins * PCR.
mRNA phenotyping - secretory granule
Introduction
The function of many tissues and cells is delineated by the
specific proteins they synthesize and secrete. The secretory
granules of neutrophils and cells of the pancreas and the sali-
vary gland have been studied extensively, and the biosynthetic
route of their cell-specific proteins has been elucidated (1, 2).
In these cell types, the proteins are endogenously synthesized
and then packaged into granules. Platelets are anucleate cells
that secrete the contents of their main storage organelles, the
a-granules, at sites ofvascular injury. The secreted substances,
together with coagulation proteins from plasma, contribute to
the formation of a hemostatic plug. Platelets arise from bone
marrow precursor cells called megakaryocytes. a-Granule
proteins such as fibrinogen and platelet factor 4 (PF-4),' albu-
Address reprint requests to Prem Handagama, Dept. of Pathology,
University of California, HSW-50 1, San Francisco, CA 94143-0506.
Receivedfor publication 1 June 1990 and in revisedform 13 July
1990.
1. Abbreviations used in this paper: PF-4, platelet factor 4; RT-PCR,
reverse transcription-polymerase chain reaction.
min, and IgG are immunohistochemically detectable in mega-
karyocytes (3, 4). Platelet fibrinogen, the predominant protein
secreted from a-granules, has been assumed to be synthesized
by megakaryocytes. Reports have indicated that megakaryo-
cyte-enriched marrow preparations synthesize fibrinogen (5, 6)
and contain fibrinogen-specific mRNA (7). However, when
IgG was localized to a-granules, the hypothesis of endocytic
origin of platelet granule proteins was presented (8). There is
recent evidence to support this hypothesis. First, we and others
have shown that when several proteins, including fibrinogen,
albumin, and IgG, are administered intravenously, they are
rapidly endocytosed by megakaryocytes and incorporated into
a-granules (3, 9-12). These proteins are later secreted by plate-
lets after stimulation with thrombin. Second, when rats are
maintained in a defibrinated state by injections of a snake
venom enzyme (ancrod) that specifically degrades fibrinogen
and removes it from the circulation, the megakaryocytes and
platelets contain markedly reduced amounts of fibrinogen
(13). Because the megakaryocyte, a cell with abundant rough
endoplasmic reticulum, is thought to be the site where most
platelet proteins are synthesized (14, 15), we undertook this
study to determine whether megakaryoctes can synthesize
these proteins.
Methods
Preparation ofcellular RNA. Rat bone marrow megakaryocytes were
enriched by a two-step process of density gradient centrifugation and
velocity sedimentation as previously described (15), except that all
procedures were carried out at 10'C, and unit gravity sedimentation
was used instead of centrifugation on a continuous Ficoll gradient.
Bone marrow megakaryocytes (2-5 X 10') at 85% to 90% purity were
processed by a microprocedure forRNA isolation that included adding
20 jug of carrier Escherichia coli rRNA to each preparation (16, 17).
Mouse megakaryocyte colonies were grown in soft agar cultures as
described previously (18-20). These colonies, composed entirely of
megakaryocytes, developed in culture from megakaryocyte colony-
forming cells (10-20 cells per colony). Colonies (30-50 with a total of
- 500-800 megakaryocytes) were harvested directly into guanidine
isothiocyanate solution containing 20 ,g ofE. coli rRNA (16, 17), and
whole RNA was purified.
RNA phenotyping by reverse transcription-polymerase chain reac-
tion (RT-PCR). RNA was reverse-transcribed with 100 U of Moloney
murine leukemia virus reverse transcriptase (Bethesda Research Labo-
ratories, Gaithersburg, MD) as previously described (16, 17), except
that 2 Iug of carrier E. coli rRNA was added to each reaction, and
primed by random hexanucleotides or oligo(dT). One-tenth ofthe RT
mixture was used in a PCR amplification primed by sequence-specific
oligonucleotides (listed in Table I [21-26]) for 60 cycles, as described
1364 P. Handagama, D. A. Rappolee, Z. Werb, J. Levin, and D. F. Bainton
J. Clin. Invest.
© The American Society for Clinical Investigation, Inc.
0021-9738/90/10/1364/05 $2.00
Volume 86, October 1990, 1364-1368
Table I. Design ofOligonucleotide Primers Usedfor RT-PCR
Diagnostic Diagnostic
5'Oligonucleotide (site 3'Oligonucleotide Fragment restriction fragment
Transcript in sequence) (site in sequence) length enzyme lengths
bp bp
Albumin 446-467 1765-1743 322 Hinc II 218 + 104
a-Fibrinogen 5738-5764 6766-6748 373 Apa I 314 + 59
#-Fibrinogen 517-546 699-673 172 Rsa I 96 + 76
y-Fibrinogen 1006-1030 1247-1225 241 Taq I 183 + 58
PF-4 161-170,424-437 744-723 192 Bam HI 118 + 74
fl-actin 25-48 268-245 243 Bgl II 152 + 91
IgG (CK) 2063-2086 4803-4780 223 Hpa I 135 + 88
Sequences are from published sources (21-26).
previously (16, 17). 8 gl ofthe 50 jtl PCR mixture was electrophoresed megakaryocytes in the RT reaction by the number ofPCR tubes into
in 4% agarose, and then stained with ethidium bromide as described which the RT mix was aliquoted. The threshold of a given mRNA
(16, 17). Products of the RT-PCR were validated by predicted size, species in the liver was then divided by the number ofmegakaryocytes
restriction enzyme analysis, or DNA bolt analysis. in each PCR tube. In a typical experiment, RNA from 1,200 colony
Calculations. To calculate the minimum threshold number of megakaryocytes was recovered at 66% yield and then analyzed in four
mRNA transcripts per megakaryocyte, we first calculated the mini- PCR reaction tubes, giving 200 megakaryocytes in each PCR tube.
mum threshold for detection of each mRNA species in the positive- With a detection threshold of 100 albumin transcripts for 200 mega-
control rat liver RNA. Each liver cell contains 100 pg of RNA (27), karyocytes, 0.5 transcripts (or less) per colony megakaryocyte would be
3,000 transcripts of fibrinogen (28; Crabtree, G. R., personal commu- detected.
nication), and 10,000 transcripts of albumin (Fausto, N., personal The threshold for number ofmRNA transcripts in a single mega-
communication). We calculated the minimum threshold for number karyocyte in a megakaryocyte-enriched bone marrow preparation was
of transcripts by multiplying the number of transcripts in a liver cell by determined by multiplying the total number of bone marrow cells by
a ratio ofthe detection threshold for the species (in picograms, given in the percentage that were megakaryocytes and multiplying that number
Table II) to the 100 pg of total RNA in a liver cell (27). Thus, (10,000 by the percentage of RNA recovered. This yielded the number of
transcripts of albumin mRNA per liver cell) X (1 pg detection thresh- megakaryocytes per RT reaction. This number was divided by the
old for albumin) + (100 pg RNA per liver cell) gives a minimum number of PCR tubes per RT reaction to yield the number of mega-
threshold of 100 transcripts of albumin. karyocytes per PCR tube. The detection threshold for a given mRNA
The threshold for number ofRNA transcripts in a single megakary- species in liver was then divided by the number of megakaryocytes in
ocyte from a colony was calculated by first multiplying the number of each PCR tube. In a typical experiment, RNA from 50,000 bone
megakaryocytes harvested by the fraction of purified RNA recovered marrow cells consisting of 90% megakaryocytes was recovered at a
(determined from recovery of the carrier rRNA because this was in yield of66%. Ifone-tenth ofthe RNA was analyzed in each PCR tube,
large excess of the megakaryocyte RNA) to give the number of mega- then each reaction contained - 3,000 megakaryocytes. For albumin,
karyocytes used in the RT reaction. The number of megakaryocytes in 0.03 transcripts (or less) per bone marrow megakaryocyte would be
each PCR reaction tube was determined by dividing the number of detected.
Table II. Summary ofmRNA Transcripts Expressed in Bone Marrow and Megakaryocytes (mk)
Calculated threshold for No. ofmRNA transcripts
Presence of transcript
Detection threshold Positive
Whole Enriched Pure mk of species in positive control Enriched Pure mk
Transcript marrow mk colonies control RNA RNA mk colonies
Pg
Fibrinogen
a +(2) -(5) -(3) 100 3000 < 1.0 . 15
ft +(I) -(3) -(3) 100 3000 <1.0 C15
ly +(2) +(4)* -(3) 10 300 <0.01 <1.5
Albumin -(2) -(4) -(1) 1 100 <0.03 <0.5
IgG (CK) +(I) ±(I)* -(1) 1 NC NC NC
PF-4 +(2) +(4) +(3) 100 NC NC NC
Samples that were positive for the specific mRNA transcripts by RT-PCR are indicated by "+", those that were negative by "-", and those that
were variable by "±". The number of experiments, each performed with two or three replicate RNA preparations, is shown in parentheses. De-
tection thresholds were determined with whole liver RNA, except for CK, which was determined with mouse spleen RNA. The minimum
thresholds for number ofmRNA transcripts in positive control RNA and megakaryocytes were derived by calculation (see Methods). NC, not
calculated. * One positive result was obtained with a preparation that had only -50% megakaryocytes.
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Figure 1. Expression ofmRNA for a, fS, or y fibrinogen, all
IgG in various cell types. (a) Example of the determination
tection threshold of a species (albumin) in a dilution series
positive control (whole rat liver) RNA processed by RT-PC
cycles. The thresholds of all RT-PCR reactions are given in
The amount ofRNA in each PCR reaction is indicated on '
scissa (in pg);M is the ladder of molecular weight markers (
Research Labs) (in bp). (b) Test of oligonucleotide primers
PCR for sources of each specific mRNA. Whole RNA from
cate samples of 100 ng of rat liver (source of a, (3, y fibrinof
min, and fl-actin) or mouse spleen (source of CK) was revert
scribed, primed by oligonucleotides, amplified by 60 cycles
and then analyzed by electrophoresis in 4% agarose gels, fol
staining with ethidium bromide. Duplicate preparations are
for each primer pair. All photographs are presented as negati
Results and Discussion
We used the method ofmRNA phenotyping to detec
transcripts for specific proteins in small numbers
Megakaryocyte RNA was obtained from three type
preparations: (a) whole rat bone marrow, in which -
the cells are megakaryocytes, (b) megakaryocyte-enr
bone marrow, in which 85%-90% of the cells are larj
II and III megakaryocytes (29), and (c) mouse megal
colonies grown in vitro for seven days. The latter two
tions correspond to the stage at which fibrinogen is I
appear in megakaryocytes (30). RNA from immatu
karyocytes, present in megakaryocyte colonies after
five days of culture, was also analyzed. The colonies
from cultures served as the source of completely pu
karyocytes, free of contamination by other cell types.
of mouse and rat liver, spleen, and macrophage R
purified and used as positive controls.
RT-PCR was sensitive enough to detect albumin
the three chains of fibrinogen (a, (3, y), and fl-actin in
a single rat or mouse liver cell. PF4 could be detect
than 100 pg of megakaryocyte RNA. RT-PCR also
mRNA transcripts for IgG in spleen (Fig. 1 b); prime
constant region of mouse IgG-K light chain (CK) M
because 90% ofmouse and rat IgGs have K chains. However, in
neither the enriched rat megakaryocyte preparations
(85%-90% pure) (Fig. 2 a) nor the pure mouse megakaryocyte
colonies grown for seven days (Fig. 2 b) could mRNA tran-
scripts for fibrinogen (a, (3, y), albumin, or IgG (CK) be de-
tected. Transcripts for fibrinogen (y) also were not detected in
immature megakaryocyte colonies grown for three or five days
(data not shown). In contrast, mRNA transcripts for PF-4 (Fig.
2 a, b) and f3-actin (Fig. 2 a, b) were easily seen in these sam-
ples. The identities of PCR fragments were validated by cut-
ting with restriction enzymes (Fig. 3). Although megakaryo-
cytes of> 85% purity did not contain detectable mRNA tran-
scripts for fibrinogen, these transcripts were detected in whole
bone marrow and in one preparation with 50% megakaryo-
cytes (Table II). IgG transcripts were detected in whole bone
marrow but not in the pure megakaryocyte colonies. Albumin
_0.11M was not detected in any sample, even though < 0.03 tran-
scripts per bone marrow megakaryocyte would have been de-
tected.
Since the RT-PCR technique was sensitive enough to have
actin detected less than one mRNA transcript per megakaryocyte,
we conclude that megakaryocytes do not synthesize fibrino-
bumin, or gen, albumin, or IgG. These data, taken together with previous
of the de- observations (3, 9-12), indicate that megakaryocytes incorpo-
of 10-fold
rate the fibrinogen, albumin, and IgG found in their a-gran-
'R for 60
Table II. ules from plasma.
the ab- Our results with fibrinogen conffict with those of previous
(Bethesda investigators (5-7), who reported that fibrinogen is synthesized
by RT- by megakaryocytes in 50%-80% pure preparations; however,
dupli- an earlier study failed to show fibrinogen synthesis in cultured
gen, albu- megakaryocytes (31). The structure and function of platelet
se-tran- fibrinogen is also a much disputed subject. Although some
of PCR, investigators have suggested that platelet fibrinogen is different
[lowed by from plasma fibrinogen (32), many ofthese differences may be
shown
ye images.
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Figure 2. (a) RT-PCR of purified rat bone marrow megakaryocytes.
(3-actin and PF-4 are endogenous megakaryocyte proteins used as
positive controls. Duplicate preparations from one of two or three
experiments are shown for each primer pair. (b) RT-PCR of mouse
megakaryocyte colonies grown in soft agar cultures for seven days.
Duplicate preparations from one of three experiments are shown for
each primer pair. M, the molecular weight markers as shown in Fig.
I a.
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Figure 3. Restriction enzyme analysis ofDNA fragments
generated by RT-PCR (arrows). The amplified fragments
(100 Al) were ethanol-precipitated and then digested with
the restriction enzymes indicated in Table I, according to
the manufacturer's instructions (Bethesda Research
Labs, Promega Biotech, Madison, WI, or New England
Biolabs, Beverly, MA). Paired digested (C) and undi-
gested (U) fragments were fractionated on 4% agarose
gels and stained with ethidium bromide. M, the molecu-
lar weight markers as shown in Fig. I a.
explained by y-chain heterogeneity and degradation during
purification (33-36). Our data suggest that bone marrow cells
other than megakaryocytes contain fibrinogen transcripts. In
preliminary experiments we found that some macrophages
and granulocyte-macrophage colonies contain fibrinogen-spe-
cific mRNA and/or immunohistochemically stainable fibrin-
ogen (data not shown). Thus, previous results indicating that
megakaryocytes synthesize fibrinogen could be due to contam-
ination with mRNA from other cells, such as macrophages. In
addition, it has been reported that megakaryocytes grown in
vitro contain fibrinogen only if the culture medium contains
fibrinogen (30). These observations are in accord with the pres-
ent data showing that megakaryocytes cannot synthesize fi-
brinogen.
The uptake and incorporation of fibrinogen into granules
by megakaryocytes and platelets is probably mediated by re-
ceptors. Assuming a normal human platelet volume of 9.6 fl
(37) and an a-granule content of - 8% ofplatelet volume (38),
the a-granule concentrations for fibrinogen (39), PF-4 (40),
albumin (41), and IgG (41) are 91.3, 41.3, 31.6, and 6.5 fg/fl,
respectively; the plasma concentrations for these proteins are
3.0, trace, 42.8, and 11.3 fg/fl, respectively. Thus, the ratios of
a-granule:plasma concentrations are 30.4, > 106, 0.7, and 0.6,
respectively. Note that the ratios of all three proteins not syn-
thesized by megakaryocytes (fibrinogen, albumin, and IgG)
are much lower than that of the endogenously synthesized
PF-4. Because the concentration of fibrinogen, but not of al-
bumin or IgG, is higher in a-granules than in plasma, the
uptake of fibrinogen may be more efficient. Megakaryocytes
and platelets possess the integrin glycoprotein (GP) Ilb-IIIa
complex, a well-characterized fibrinogen receptor (42). It is
tempting to hypothesize that this receptor mediates the uptake
of fibrinogen by megakaryocytes and platelets, because pa-
tients with Glanzmann's thrombasthenia, who have a congeni-
tal platelet GPIIb-IIIa deficiency, have an unexplained parallel
deficiency ofplatelet fibrinogen (43, 44). In'contrast, a-granule
albumin and IgG are probably acquired by fluid-phase endo-
cytosis (45). This hypothesis is supported by the observed cor-
relation between the concentrations of albumin and IgG in
platelets and plasma over a wide range of normal and abnor-
mal values (41).
In summary, megakaryocytes and platelets appear to have
two mechanisms for acquiring proteins for their major secre-
tory organelle, the a-granules. Some proteins, such as PF-4, are
endogenously synthesized, whereas others are endocytosed
from plasma. It may be possible to use the endocytic pathway
to insert pharmacological agents into platelet a-granules, per-
haps by attaching a receptor recognition sequence to the drug.
This pathway could serve as a new way to deliver drugs to sites
of platelet activation, such as areas of vascular injury and
thrombi.
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